Tag: Ilumya’

spot_img

Tildrakizumab for Treatment of Moderate-to-Severe Plaque Psoriasis: Could Sun Pharma’s ‘Ilumya’ be a Better Option?

Tildrakizumab is being marketed by Sun Pharma under the trade name Ilumya, and has been approved by FDA in March 2018 after analysis of...

Stay in touch:

87,438FansLike
41,860FollowersFollow
1,772FollowersFollow
49SubscribersSubscribe

Newsletter

Don't miss

Outbreak of Bundibugyo Ebolavirus in DR Congo and Uganda

The current orthoebolavirus outbreak in Democratic Republic of Congo...

Neanderthals Performed Dental Caries Interventions 59,000 Years Ago

Prehistoric dentistry is far older than 14,000 years as...

Brain-Computer Interfaces (BCI): Towards Humans’ Merger with AI 

The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such...

Tumour Treating Fields (TTFields) approved for Pancreatic cancer

Cancer cells have electrically charged parts hence are influenced...

Scientific European invites Co-founder

Scientific European (SCIEU) invites you to join as a Co-Founder and investor, with both...